Amdocs Stock Insiders

DOX
 Stock
  

USD 83.34  0.43  0.52%   

Amdocs employes about 29 K people. The company is managed by 19 executives with total tenure of roughly 226 years, averaging almost 11.0 years of service per executive having 1526.32 employees per reported executive. Break down of Amdocs management performance can provide insight into the company performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with Amdocs Limited future performance.
Continue to Investing Opportunities.
  
Refresh
  Eli Gelman  CEO
Director, Member of Technology and Innovation Committee, CEO of Amdocs Management Limited and President of Amdocs Management Limited
  Robert Minicucci  Chairman
Independent Chairman of the Board
  Tamar RapaportDagim  President
Senior Vice President and CFO of Amdocs Management Limited

Amdocs Return on Sales

0.22

Share

Amdocs Management Team Effectiveness

Amdocs Limited has Return on Asset of 5.76 % which means that on every $100 spent on asset, it made $5.76 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 14.03 %, implying that it generated $14.03 on every 100 dollars invested. Amdocs management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. Return on Invested Capital is likely to rise to 0.44 in 2022, whereas Return on Investment is likely to drop 12.42 in 2022. Amdocs Tax Assets are fairly stable at the moment as compared to the past year. Amdocs reported Tax Assets of 135.66 Million in 2021. Revenue to Assets is likely to rise to 0.60 in 2022, whereas Total Assets are likely to drop slightly above 7 B in 2022.
Amdocs Weighted Average Shares is fairly stable at the moment as compared to the past year. Amdocs reported Weighted Average Shares of 118.38 Million in 2021. Weighted Average Shares Diluted is likely to rise to about 148.1 M in 2022, whereas Issuance Purchase of Equity Shares is likely to drop (573.8 M) in 2022.

Amdocs Workforce Comparison

Amdocs Limited is one of the top stocks in number of employees category among related companies. The total workforce of Software—Infrastructure industry is currently estimated at about 58,000. Amdocs totals roughly 29,000 in number of employees claiming about 50% of equities listed under Software—Infrastructure industry.

Amdocs Profit Margins

The company has Net Profit Margin of 12.13 %, which may imply that it executes well on its competitive polices and has reasonable control over its expenses and variable costs. This is very large. In the same way, it shows Net Operating Margin of 14.36 %, which entails that for every 100 dollars of revenue, it generated 0.14 of operating income.

Amdocs Notable Stakeholders

An Amdocs stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Amdocs often face trade-offs trying to please all of them. Amdocs' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Amdocs' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Eli Gelman - Director, Member of Technology and Innovation Committee, CEO of Amdocs Management Limited and President of Amdocs Management LimitedProfile
Robert Minicucci - Independent Chairman of the BoardProfile
Tamar RapaportDagim - Senior Vice President and CFO of Amdocs Management LimitedProfile
Anshoo Gaur - Division President of Amdocs Devel. Center India Pvt LtdProfile
Shuky Sheffer - Senior Vice President and President of Customer Business Group, Amdocs Management LimitedProfile
Rajat Raheja - Division President Amdocs Development Center India Pvt. LtdProfile
Richard LeFave - Independent DirectorProfile
John MacDonald - DirectorProfile
Adrian Gardner - Independent DirectorProfile
Zohar Zisapel - Independent DirectorProfile
Simon Olswang - Independent DirectorProfile
Giora Yaron - DirectorProfile
John McLennan - Independent DirectorProfile
Clayton Christensen - DirectorProfile
Julian Brodsky - Independent DirectorProfile
James Kahan - Independent DirectorProfile
Elizabeth McDermon - Secretary and VP of Corporate Strategy of Amdocs Inc.Profile
Matthew Smith - Corporate SecretaryProfile
Matt Smith - IR Contact OfficerProfile

About Amdocs Management Performance

The success or failure of an entity such as Amdocs Limited often depends on how effective the management is. Amdocs management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Amdocs management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Amdocs management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please read more on our stock advisor page.
Last ReportedProjected for 2022
Return on Investment 12.53  12.42 
Return on Average Assets 0.12  0.11 
Return on Average Equity 0.22  0.19 
Return on Invested Capital 0.33  0.44 
Return on Sales 0.22  0.19 
Amdocs Limited, through its subsidiaries, provides software and services worldwide. Amdocs Limited was founded in 1988 and is headquartered in Chesterfield, Missouri. Amdocs operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. It employs 29000 people.
The data published in Amdocs' official financial statements usually reflect Amdocs' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Amdocs Limited. For example, before you start analyzing numbers published by Amdocs accountants, it's critical to develop an understanding of what Amdocs' liquidity, profitability, and earnings quality are in the context of the Technology space in which it operates.
Please note, the presentation of Amdocs' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Amdocs' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Amdocs' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Amdocs Limited. Please utilize our Beneish M Score to check the likelihood of Amdocs' management to manipulate its earnings.

Amdocs Workforce Analysis

Traditionally, organizations such as Amdocs use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Amdocs within its industry.

Amdocs Manpower Efficiency

Return on Amdocs Manpower

Revenue Per Employee141.1 K
Revenue Per Executive226.8 M
Net Income Per Employee19.8 K
Net Income Per Executive27.5 M
Working Capital Per Employee25.3 K
Working Capital Per Executive38.7 M
Today, most investors in Amdocs Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Amdocs' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's per employee growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Amdocs per employee as a starting point in their analysis.

Per Employee

Amdocs Per Employee Growth Over Time

Net Income Per Employee

19,834.24

Share
Amdocs Net Income Per Employee is fairly stable at the moment as compared to the past year. Amdocs reported Net Income Per Employee of 22,797 in 2021

Revenue Per Employee

141,065

Share
Amdocs Revenue Per Employee is fairly stable at the moment as compared to the past year. Amdocs reported Revenue Per Employee of 142,029 in 2021
Continue to Investing Opportunities. Note that the Amdocs Limited information on this page should be used as a complementary analysis to other Amdocs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Tools for Amdocs Stock

When running Amdocs Limited price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go